GRI Bio, Inc. (GRI)
2.565
+0.16
(+6.88%)
USD |
NASDAQ |
Mar 06, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
GRI Bio EPS Diluted (Quarterly) : -5.343 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.567 |
| Ekso Bionics Holdings, Inc. | -1.568 |
| Akari Therapeutics Plc | -0.1947 |
| Moleculin Biotech, Inc. | -17.02 |
| Autonomix Medical, Inc. | -0.3641 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.659M |
| Total Expenses (Quarterly) | 2.659M |
| Enterprise Value | -4.452M |
| Earnings Yield | -3.26K% |
| Normalized Earnings Yield | -3264.65 |